Cardiac and hepatic effects of pre- and postnatal exposure to polybrominated biphenyls in rats

Insights

Polybrominated biphenyls (PBBs) exposure in rats reduced body weight gain and vitamin A levels. While PBBs altered liver function and porphyrin excretion, they minimally impacted cardiac contractile function.

Area of Science:

  • Toxicology
  • Environmental Health
  • Pharmacology

Background:

  • Polybrominated biphenyls (PBBs) are persistent organic pollutants with known toxic effects.
  • Understanding the specific impacts of PBBs on organ systems is crucial for risk assessment.

Purpose of the Study:

  • To investigate the effects of pre- and postnatal polybrominated biphenyls (PBBs) exposure on Sprague-Dawley rats.
  • To assess the impact of PBBs on body weight, liver function, and cardiac function.

Main Methods:

  • Sprague-Dawley rats were exposed to 100 ppm of polybrominated biphenyls (PBBs) pre- and postnatally.
  • Evaluated body weight gain, liver weight to body weight ratio, hepatic vitamin A concentrations, and hepatic delta-aminolevulinic acid (ALA) synthetase activity.
  • Measured urinary excretion of uro- and coproporphyrins and assessed cardiac contractile function, including inotropic responses to calcium and ouabain.

Main Results:

  • PBBs exposure significantly reduced body weight gain and hepatic vitamin A concentrations.
  • Increased liver weight to body weight ratio, hepatic delta-aminolevulinic acid (ALA) synthetase activity, and urinary uro- and coproporphyrin excretion were observed.
  • PBBs enhanced the left atrial inotropic response to calcium but did not affect adrenergic neuronal transport, baselike peak tension, or ouabain response in the heart.

Conclusions:

  • Pre- and postnatal PBBs exposure retards body weight gain and induces significant alterations in liver function and porphyrin metabolism in rats.
  • Cardiac contractile function was largely unaffected by PBBs exposure, suggesting organ-specific toxicity.